Calidi Biotherapeutics, Inc. Retained Earnings
Calidi Biotherapeutics, Inc. (CLDI) had Retained Earnings of -$149.89 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$149.89M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$145.73M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$141.62M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$137.56M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$149.89M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$145.73M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$141.62M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$137.56M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$132.42M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | -$126.70M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$121.72M 10-K · filed 2026-03-27 | |
| 2024-09-30 | -$117.62M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$112.56M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$106.80M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$99.57M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$91.34M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$12.15M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | -$7.88M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$70.36M 10-K · filed 2024-03-15 | -$5.21M 10-K · filed 2023-03-31 |
| 2022-09-30 | -$9.90M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$9.24M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | -$13.24M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$14.69M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$18.98M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |